Omega Healthcare Investors (OHI) Cash & Equivalents (2009 - 2026)

Omega Healthcare Investors (OHI) has 18 years of Cash & Equivalents data on file, last reported at $26.1 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 27.6% year-over-year to $26.1 million; the trailing twelve-month figure through Mar 2026 stood at $26.1 million (down 27.6% YoY), and the FY2025 full-year result was $27.0 million, down 11.09% from the prior year.
• Cash & Equivalents eased to $26.1 million in Q1 2026, from $27.0 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $737.2 million in Q3 2025 to a low of $1.3 million in Q1 2024.
• A 5-year average of $181.4 million and a median of $36.1 million in 2025 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents slumped 99.49% in 2024 and jumped 10636.76% in 2025, its largest moves.
• Tracing OHI's Cash & Equivalents over 5 years: stood at $297.1 million in 2022, then surged by 49.04% to $442.8 million in 2023, then sank by 93.14% to $30.4 million in 2024, then decreased by 11.09% to $27.0 million in 2025, then declined by 3.24% to $26.1 million in 2026.
• Business Quant data shows OHI's Cash & Equivalents at $26.1 million in Q1 2026, $27.0 million in Q4 2025, and $737.2 million in Q3 2025.